Compare MERC & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MERC | BTMD |
|---|---|---|
| Founded | 1968 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Paper | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.2M | 65.8M |
| IPO Year | 2005 | 2021 |
| Metric | MERC | BTMD |
|---|---|---|
| Price | $0.64 | $2.37 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $2.25 | ★ $2.83 |
| AVG Volume (30 Days) | ★ 785.0K | 410.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.01% | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $1,169,145,000.00 | $192,219,000.00 |
| Revenue This Year | $13.75 | $2.03 |
| Revenue Next Year | $10.12 | $6.58 |
| P/E Ratio | ★ N/A | $36.33 |
| Revenue Growth | ★ 25.50 | N/A |
| 52 Week Low | $0.53 | $1.27 |
| 52 Week High | $4.47 | $4.75 |
| Indicator | MERC | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.40 | 58.73 |
| Support Level | N/A | $2.37 |
| Resistance Level | $0.81 | $2.44 |
| Average True Range (ATR) | 0.07 | 0.17 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 43.61 | 96.75 |
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the maximum of revenue is generated from the China. The majority of the revenue is generated from the Pulp segment.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.